Zobrazeno 1 - 10
of 73
pro vyhledávání: '"D. Heldal"'
Autor:
M. Remberger, B. Grønvold, M. Ali, J. Mattsson, T. Egeland, K. U. Lundin, A. Myhre, I. Abrahamsen, D. Heldal, I. Dybedal, G. E. Tjønnfjord, T. Gedde-Dahl, Y. Fløisand
Publikováno v:
Clinical Hematology International, Vol 2, Iss 2 (2020)
The effect of CD34+ cell dose in allogeneic hematopoietic stem cell transplantation (HSCT) on overall survival (OS) and incidence of acute and chronic graft-versus-host disease (GvHD) has not been established and few studies have been performed. Our
Externí odkaz:
https://doaj.org/article/dcd573a286f44e1c836d2da62f9daeef
Autor:
B. Grønvold, Maryan Ali, Yngvar Fløisand, Ingerid Weum Abrahamsen, Jonas Mattsson, Ingunn Dybedal, Anders Eivind Myhre, Katrin U. Lundin, M. Remberger, Geir E. Tjønnfjord, Thore Egeland, T. Gedde-Dahl, D. Heldal
Publikováno v:
Bone Marrow Transplantation. 55:1658-1661
Autor:
M, Remberger, B, Grønvold, M, Ali, J, Mattsson, T, Egeland, K U, Lundin, A, Myhre, I, Abrahamsen, D, Heldal, I, Dybedal, G E, Tjønnfjord, T, Gedde-Dahl, Y, Fløisand
Publikováno v:
Clinical Hematology International
The effect of CD34+ cell dose in allogeneic hematopoietic stem cell transplantation (HSCT) on overall survival (OS) and incidence of acute and chronic graft-versus-host disease (GvHD) has not been established and few studies have been performed. Our
Autor:
Hans Hägglund, Maija Itälä-Remes, Riita Niittyvuopio, Anna Sandstedt, Gunnar Larfors, Anne Fischer-Nielsen, Ulla Axdorph-Nygell, Stig Lenhoff, Simon Pahnke, Jan-Erik Johansson, Marjut Kauppila, D. Heldal, Per Ljungman, Eva Haastrup
Publikováno v:
Journal of Clinical Apheresis. 33:226-235
The Nordic Register of Haematopoietic Stem Cell Donors (NRHSD) has registered related and unrelated donors from 10 transplant centres in Sweden, Norway, Finland and Denmark since 1998. We present a prospective, observational study of 1,957 donors, fo
Autor:
B, Grønvold, M M, Ali, M, Remberger, J, Mattsson, T, Egeland, K U, Lundin, A E, Myhre, I W, Abrahamsen, D, Heldal, I, Dybedal, G E, Tjønnfjord, Y, Fløisand, T, Gedde-Dahl
Publikováno v:
Bone marrow transplantation. 55(8)
Autor:
Arne Kolstad, Peter Gaustad, Halvor Rollag, Ciǧdem Akalin Akkök, Pål Andre Holme, Yngvar Fløisand, Stein Bergan, D. Heldal, Tobias Gedde-Dahl, Gunnar Kvalheim, Dag Josefsen, Magnus Andreas Rognlien Husøy, Lorentz Brinch, Geir E. Tjønnfjord, Torstein Egeland, I. Dybedal
Publikováno v:
Tidsskrift for Den norske legeforening. 134:1569-1575
BACKGROUND Allogeneic stem cell transplantation (ASCT) has been a treatment option for patients with serious diseases of the blood and haematopoietic organs in Norway since 1985. Such treatment is potentially curative for selected patients who have a
Autor:
D. Heldal, T. Gedde-Dahl, I. Abrahamsen, M.M. Ali, M. Remberger, Katrin U. Lundin, J. Mattsson, B. Grønvold, Geir E. Tjønnfjord, Yngvar Fløisand, A. Myhre, Thore Egeland, I. Dybedal
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S298
High-resolution matching of donor-recipient HLA improves outcome in allogeneic stem cell transplants. Matching for HLA-A, -B, -C, –DRB1 and –DQ is mandatory in our transplant centre, to identify 10/10 or 9/10 matched unrelated donors. High resolu
Autor:
Arne Kolstad, D. Heldal, Alexander Fosså, E. Aurlien, Yngvar Fløisand, Grete F. Lauritzsen, Gunnar Kvalheim, Torstein Egeland, Tobias Gedde-Dahl, D.H. Fowler, Harald Holte, I. Dybedal, Geir E. Tjønnfjord, Lorentz Brinch, Gustav Lehne, Dag Torfoss, E. Baggerød, Michael R. Bishop
Publikováno v:
Bone Marrow Transplantation. 47:1552-1557
Reduced-intensity conditioning (RIC) allo-SCT is a potentially curative treatment approach for patients with relapsed Hodgkin's or non-Hodgkin's lymphoma. In the present study, 37 patients underwent RIC allo-SCT after induction treatment with EPOCH-F
Publikováno v:
Case Reports in Hematology, Vol 2014 (2014)
Case Reports in Hematology
Case Reports in Hematology
Good’s syndrome is a rare acquired immunodeficiency associated with thymoma. Eltrombopag is a thrombopoietin receptor agonist and has been shown to be a valuable supplement to the treatment of several types of refractory cytopenias. In this paper,
Publikováno v:
Journal of Hematotherapy. 6:563-573
Comparative studies of the CD34+ cell population in peripheral blood (PB) and bone marrow (BM) may contribute to understanding the mechanisms involved in mobilization of hematopoietic progenitor cells (HPCs) from BM to PB. PB-CD34+ and BM-CD34+ cells